Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000411347) titled 'The CHAMPION-MTX trial: Child Hood Arthritis Multi-omic Predictions Improving Outcomes Nationally-Methotrexate Taper eXperiment' on April 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Open (masking not used)
Assignment: Parallel
Type of endpoint: Safety/efficacy
Primary Sponsor: University of Sydney
Condition:
Juvenile idiopathic arthritis (JIA)
Juvenile idiopathic arthritis (JIA)
Musculoskeletal - Other muscular and skeletal disorders
Inflammatory and Immune System - Autoimmune diseases
Intervention:
Participants in CHAMPION-MTX are car...